238 related articles for article (PubMed ID: 23257292)
21. Post-translational modifications and the Warburg effect.
Hitosugi T; Chen J
Oncogene; 2014 Aug; 33(34):4279-85. PubMed ID: 24096483
[TBL] [Abstract][Full Text] [Related]
22. The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.
Shen L; Sun X; Fu Z; Yang G; Li J; Yao L
Clin Cancer Res; 2012 Mar; 18(6):1561-7. PubMed ID: 22307140
[TBL] [Abstract][Full Text] [Related]
23. Cancer-like metabolism of the mammalian retina.
Ng SK; Wood JP; Chidlow G; Han G; Kittipassorn T; Peet DJ; Casson RJ
Clin Exp Ophthalmol; 2015; 43(4):367-76. PubMed ID: 25330055
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria in cancer: at the crossroads of life and death.
Fogg VC; Lanning NJ; Mackeigan JP
Chin J Cancer; 2011 Aug; 30(8):526-39. PubMed ID: 21801601
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy.
Scatena R; Bottoni P; Pontoglio A; Giardina B
Proteomics Clin Appl; 2010 Feb; 4(2):143-58. PubMed ID: 21137040
[TBL] [Abstract][Full Text] [Related]
26. p53 and glucose metabolism: an orchestra to be directed in cancer therapy.
Gomes AS; Ramos H; Soares J; Saraiva L
Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896
[TBL] [Abstract][Full Text] [Related]
27. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
Yalcin A; Telang S; Clem B; Chesney J
Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
[TBL] [Abstract][Full Text] [Related]
28. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes.
Levine AJ; Puzio-Kuter AM
Science; 2010 Dec; 330(6009):1340-4. PubMed ID: 21127244
[TBL] [Abstract][Full Text] [Related]
29. The Warburg effect: insights from the past decade.
Upadhyay M; Samal J; Kandpal M; Singh OV; Vivekanandan P
Pharmacol Ther; 2013 Mar; 137(3):318-30. PubMed ID: 23159371
[TBL] [Abstract][Full Text] [Related]
30. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis.
Sajnani K; Islam F; Smith RA; Gopalan V; Lam AK
Biochimie; 2017 Apr; 135():164-172. PubMed ID: 28219702
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
32. 'The metabolism of tumours': 70 years later.
Semenza GL; Artemov D; Bedi A; Bhujwalla Z; Chiles K; Feldser D; Laughner E; Ravi R; Simons J; Taghavi P; Zhong H
Novartis Found Symp; 2001; 240():251-60; discussion 260-4. PubMed ID: 11727934
[TBL] [Abstract][Full Text] [Related]
33. Mitochondria in cancer: not just innocent bystanders.
Frezza C; Gottlieb E
Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
[TBL] [Abstract][Full Text] [Related]
34. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
[TBL] [Abstract][Full Text] [Related]
35. Genetically-defined metabolic reprogramming in cancer.
Mullen AR; DeBerardinis RJ
Trends Endocrinol Metab; 2012 Nov; 23(11):552-9. PubMed ID: 22858391
[TBL] [Abstract][Full Text] [Related]
36. Warburg and Krebs and related effects in cancer.
Unterlass JE; Curtin NJ
Expert Rev Mol Med; 2019 Sep; 21():e4. PubMed ID: 31558177
[TBL] [Abstract][Full Text] [Related]
37. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
38. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic features of the glucose metabolism in tumor cells.
Herling A; König M; Bulik S; Holzhütter HG
FEBS J; 2011 Jul; 278(14):2436-59. PubMed ID: 21564549
[TBL] [Abstract][Full Text] [Related]
40. Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.
Yu C; Xue J; Zhu W; Jiao Y; Zhang S; Cao J
Tumour Biol; 2015 Jan; 36(1):81-94. PubMed ID: 25431262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
